查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1654288

無菌注射 CDMO 市場規模、佔有率、趨勢分析報告：按分子類型、產品、服務、治療領域、給藥途徑、最終用途、地區、細分預測，2025-2030 年

Sterile Injectables CDMO Market Size, Share & Trends Analysis Report By Molecule Type (Small Molecule, Large Molecule), By Product, By Service, By Therapeutic Area, By Route Of Administration, By End-use, By Region, And Segment Forecasts, 2025 - 2030
出版日期: | 出版商: Grand View Research | 英文 180 Pages | 商品交期: 2-10個工作天內

價格

無菌注射 CDMO 市場趨勢：

預計 2024 年全球無菌注射 CDMO 市場規模為 42.5 億美元，2025 年至 2030 年複合年成長率為 9.61%。

市場成長的主要動力是注射藥物的不斷增加和核准。製藥公司正積極致力於開發具有眾多優勢的注射藥物，包括起效更快、給藥更準確、患者依從性更高。

例如，根據美國食品藥物管理局（FDA）2024年1月發布的報告，藥品評估和研究中心（CDER）在2023年核准了55種新藥。這些藥物還包括注射劑，顯示其產品線強大。預計該管道將推動商業和研究用途的契約製造服務需求的成長，從而促進整體市場的成長。

對細胞和基因治療的需求不斷增加正在推動市場成長。隨著治療管道的擴大，對受託製造廠商(CMO) 提供的專業製造能力的需求日益增加。例如，根據美國基因和細胞治療學會（ASGCT）的數據，目前有 3,866 種治療方法正在開發中，從臨床前到預註冊階段。其中，2082種治療方法被歸類為基因療法，包括CAR-T細胞療法等基因改造細胞療法，佔基因、細胞和RNA療法的53%。此外，862 種治療方法是非基因改造細胞療法，佔所有正在開發的基因、細胞和 RNA治療方法的 22%。因此，強大的產品平臺和對先進治療藥物不斷成長的需求可能會推動整體市場需求。

市場參與企業正在採取擴大無菌生產設施、合作研究和夥伴關係等策略性舉措，預計這些舉措將在整個預測期內推動市場成長。例如，2024 年 3 月，Alkami Corporation 與 Tanvex CDMO 合作，以增強其生技藥品製造能力。 Alcami 將利用其無菌填充、標籤和包裝專業知識，而 Tanvex 將提供高通量原料藥開發服務。此次夥伴關係旨在滿足對專科治療和複雜生技藥品日益成長的需求，並加速無菌注射劑的供應。

無菌注射劑的高需求推動了製造外包和生物製藥公司之間的委託安排的成長，從而促進了無菌注射劑 CDMO 行業的成長。對藥物快速作用、快速吸收和較低藥物濃度的日益成長的需求是推動無菌注射劑 CDMO 行業發展的一些主要方面。此外，積極參與無菌注射劑開發和製造的製藥公司正在獲得支持，以支持單株抗體療法、聚合物注射和感染疾病藥物。推動市場成長的因素有幾個，包括縮短時間、非專利注射劑成本降低、以及罕見疾病治療的進步。

先進的製造技術對於確保抗癌藥物的穩定性和有效性至關重要。專門生產無菌注射劑的契約製造製造商，特別是那些具有處理複雜配方或生物製藥經驗的製造商，能夠很好地滿足腫瘤治療的獨特要求。無菌注射劑對於輸送複雜的生技藥品和腫瘤學創新治療方法至關重要，推動了無菌注射合約製造業的成長。預計預測期內外包的成長將推動該產業的擴張。製藥公司，尤其是專門從事腫瘤學的製藥公司，擴大轉向外包製造外包業務可以提供的專業知識。這一轉變極大地促進了腫瘤領域無菌注射劑的受託製造。

目錄

第1章調查方法與範圍

第 2 章執行摘要

3. 無菌注射 CDMO 市場變數、趨勢與範圍

  • 市場展望
    • 母市場展望
    • 補貼市場前景
  • 市場動態
    • 市場促進因素分析
    • 市場限制因素分析
  • 技術進步
  • 定價模式分析
  • 2023 年臨床試驗數量分析
    • 各地區臨床試驗總數（2023 年）
    • 各階段臨床試驗總數（2023 年）
    • 依研究設計分類的臨床試驗總數（2023 年）
    • 按主要治療領域分類的臨床試驗總數（2023 年）
  • 無菌注射 CDMO 市場：分析工具
    • 波特五力分析
    • PESTEL 分析
  • COVID-19影響分析

4. 無菌注射 CDMO 市場：分子類型估計與趨勢分析

  • 細分儀表板
  • 全球無菌注射劑CDMO市場波動分析
  • 2018 年至 2030 年全球無菌注射 CDMO 市場規模及趨勢分析（依分子類型）
  • 小分子
  • 大分子

5. 無菌注射 CDMO 市場：產品預估與趨勢分析

  • 細分儀表板
  • 全球無菌注射劑CDMO市場波動分析
  • 2018 年至 2030 年全球無菌注射 CDMO 市場規模與趨勢分析（依產品分類）
  • 預填充式注射器
  • 管瓶和安瓿瓶
  • 特殊注射
  • 其他

6. 無菌注射 CDMO 市場：服務評估與趨勢分析

  • 細分儀表板
  • 全球無菌注射劑CDMO市場波動分析
  • 2018 年至 2030 年全球無菌注射 CDMO 市場規模與趨勢分析（按服務分類）
  • 配方開發
  • 分析和測試服務
    • 方法開發和檢驗
    • 穩定性測試
    • 萃取和浸出試驗
    • 其他
  • 製造業
    • 臨床試驗製造
    • 商業製造
    • 無菌灌裝及封口服務
  • 包裝
  • 貯存
    • 冷藏
    • 非冷藏
  • 其他

第 7 章。

  • 細分儀表板
  • 全球無菌注射劑CDMO市場治療領域變遷分析
  • 2018 年至 2030 年全球無菌注射 CDMO 市場規模與趨勢分析、治療領域
  • 腫瘤學
  • 心血管疾病
  • 中樞神經系統疾病
  • 感染疾病
  • 肌肉骨骼疾病
  • 荷爾蒙失調
  • 其他

8. 無菌注射 CDMO 市場：給藥途徑估計與趨勢分析

  • 細分儀表板
  • 全球無菌注射 CDMO 市場 - 給藥途徑變化分析
  • 2018 年至 2030 年全球無菌注射 CDMO 市場規模與趨勢分析、給藥途徑
  • 皮下（SC）
  • 靜脈注射 (IV)
  • 肌肉注射 (IM)
  • 其他

第 9 章。

  • 細分儀表板
  • 全球無菌注射 CDMO 市場最終用途變化分析
  • 全球無菌注射 CDMO 市場規模與趨勢分析、最終用途，2018 年至 2030 年
  • 製藥公司
  • 生物製藥公司
  • 其他

第 10 章 無菌注射 CDMO 市場：區域估計與趨勢分析

  • 2024 年及 2030 年區域市場佔有率分析
  • 區域市場儀表板
  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 丹麥
    • 瑞典
    • 挪威
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 韓國
    • 澳洲
    • 泰國
    • 越南
    • 印尼
    • 馬來西亞
    • 菲律賓
    • 新加坡
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中東和非洲
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 科威特

第11章 競爭格局

  • 市場參與企業分類
    • 市場領導者
    • 新興企業
  • 服務熱圖分析（企業間比較分析）
  • 公司簡介
    • Boehringer Ingelheim International GmbH
    • Baxter Simtra Bio Pharma Solutions
    • Vetter Pharma International GmbH
    • Recipharm AB
    • Aenova Group
    • Fresenius Kabi Contract Manufacturing（Fresenius Kabi AG）
    • Unither Pharmaceuticals
    • FAMAR Health Care Services
    • Ajinomoto Bio-Pharma
    • PCI Pharma Services
    • IDT Biologika GmbH
    • Alcami Corporation
    • Fareva Group
    • Eurofins Scientific
    • Siegfried AG
    • Torbay Pharmaceuticals
    • Pfizer CentreOne（Pfizer Inc）
Product Code: GVR-4-68040-363-5

Sterile Injectables CDMO Market Trends:

The global sterile injectables CDMO market size was estimated at USD 4.25 billion in 2024 and is projected to grow at a CAGR of 9.61% from 2025 to 2030. The market growth is primarily driven by increasing pipeline and approvals of injectable drugs. Pharmaceutical companies are proactively focusing on developing injectable medications due to their numerous benefits, such as quicker onset of action, precise dosing, and enhanced patient adherence.

For instance, as per the U.S. Food and Drug Administration (FDA) report published in January 2024, the Center for Drug Evaluation and Research (CDER) approved 55 novel drugs in 2023. These medications included injectables, indicating a robust pipeline that is anticipated to drive an increase in the demand for contract manufacturing services for both commercial and research purposes, hence contributing to overall market growth.

The increasing demand for cellular and genetic therapies is driving the market's growth. With the expansion of therapy pipelines, there is a rising requirement for specialized manufacturing capabilities provided by contract manufacturing organizations (CMOs). For instance, according to the American Society of Gene & Cell Therapy (ASGCT), 3,866 therapies are currently in development, spanning from preclinical stages through preregistration. Within this landscape, 2,082 therapies are categorized as gene therapies, which include genetically modified cell therapies like CAR T-cell therapies, constituting 53% of gene, cell, and RNA therapies. In addition, 862 therapies are nongenetically modified cell therapies, making up 22% of the overall gene, cell, and RNA therapies in development. Thus, a strong product pipeline and growing demand for advanced therapeutics are likely to enhance overall market demand.

Strategic initiatives undertaken by market participants, such as expanding sterile manufacturing facilities and engaging in collaborations and partnerships, are anticipated to bolster market growth throughout the projected period. For instance, in March 2024, Alcami Corporation company partnered with Tanvex CDMO, enhancing its capabilities in biologics manufacturing. Alcami would leverage its expertise in sterile filling, labeling, and packaging, while Tanvex would contribute its high-throughput bulk drug substance development services. The partnership aimed to expedite the delivery of sterile injectables, addressing the increasing demand for specialty therapeutics and complex biologics.

The high demand for sterile injectables propels growth in outsourced agreements amongst contract manufacturers and biopharmaceutical companies, thereby boosting the growth of the sterile injectable CDMO industry. The growing need for faster drug action, rapid absorption, and less drug concentration are a few major aspects contributing to the adoption of sterile injectables CDMO industry. Further, pharmaceutical firms actively involved in sterile injectable development and manufacturing are gaining traction to support monoclonal antibody therapies, large-molecule injectable drugs, and infectious disease-treating drugs. Several factors, including reduced time and cost-affordable research and development cycles of generic injectables and the growing advancements in rare disease treatments, are accelerating the market growth.

Advanced manufacturing techniques are crucial for ensuring the stability and efficacy of cancer therapies. Contract manufacturers specializing in sterile injectables, particularly those experienced in handling complex formulations and biologics, are well-equipped to address the specific requirements of oncology drugs. Sterile injectables are essential for delivering complex biologics and innovative treatment methods in cancer treatment, driving the growth of the sterile injectable contract manufacturing sector. The growth in outsourcing practices is expected to drive the expansion of the segment over the forecast period. Pharmaceutical companies, particularly those specializing in oncology, are increasingly turning to outsourcing manufacturing operations to streamline processes, cut costs, and capitalize on the specialized expertise offered by contract manufacturers. This shift has notably boosted the cancer sector's sterile injectable contract development and manufacturing market.

Global Sterile Injectables CDMO Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2018 to 2030. For this study, Grand View Research has segmented the global sterile injectables CDMO market report based on molecule type, product, service, therapeutic area, route of administration, end-use, and region.

  • Molecule Type Outlook (Revenue, USD Million, 2018 - 2030)
  • Small Molecule
  • Large Molecule
  • Product Outlook (Revenue, USD Million, 2018 - 2030)
  • Pre-filled Syringes
  • Vials and Ampoules
  • Specialty Injectables
  • Others
  • Service Outlook (Revenue, USD Million, 2018 - 2030)
  • Formulation Development
  • Analytical and Testing Services
    • Method Development and Validation
    • Stability Testing
    • Drug Substance
    • Stability Indicating Method Validation
    • Accelerated Stability Testing
    • Photostability Testing
    • Other Stability Testing Methods
    • Extractable & Leachable Testing
    • Others
  • Manufacturing
    • Clinical Trial Manufacturing
    • Commercial Manufacturing
    • Aseptic Fill-Finish Services
  • Packaging
  • Storage
    • Cold
    • Non-cold
  • Others
  • Therapeutic Area Outlook (Revenue, USD Million, 2018 - 2030)
  • Oncology
  • Cardiovascular Diseases
  • Central Nervous System Diseases
  • Infectious Disorders
  • Musculoskeletal Diseases
  • Hormonal Diseases
  • Others
  • Route of Administration Outlook (Revenue, USD Million, 2018 - 2030)
  • Subcutaneous (SC)
  • Intravenous (IV)
  • Intramuscular (IM)
  • Others
  • End-use Outlook (Revenue, USD Million, 2018 - 2030)
  • Pharmaceutical Companies
  • Biopharmaceutical Companies
  • Others
  • Regional Outlook (Revenue, USD Million, 2018 - 2030)
  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • UK
    • Germany
    • France
    • Italy
    • Spain
    • Denmark
    • Sweden
    • Norway
  • Asia Pacific
    • Japan
    • China
    • India
    • South Korea
    • Australia
    • Thailand
    • Vietnam
    • Indonesia
    • Malaysia
    • Philippines
    • Singapore
  • Latin America
    • Brazil
    • Argentina
  • Middle East and Africa (MEA)
    • South Africa
    • Saudi Arabia
    • UAE
    • Kuwait

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Market Definition
    • 1.2.1. Molecule Type
    • 1.2.2. Product
    • 1.2.3. Service
    • 1.2.4. Therapeutic Area
    • 1.2.5. Route of Administration
    • 1.2.6. End Use
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased Database
    • 1.4.2. GVR's Internal Database
    • 1.4.3. Secondary Sources
    • 1.4.4. Primary Research
  • 1.5. Information or Data Analysis
    • 1.5.1. Data Analysis Models
  • 1.6. Market Formulation & Validation
    • 1.6.1. Region Wise Market: Base Estimates
    • 1.6.2. Global Market: CAGR Calculation
  • 1.7. Model Details
    • 1.7.1. Commodity Flow Analysis (Model 1)
    • 1.7.2. Value-Chain-Based Sizing & Forecasting (Model 2)
    • 1.7.3. QFD Model Sizing & Forecasting (Model 3)
    • 1.7.4. Bottom-Up Approach (Model 4)
  • 1.8. List of Secondary Sources
  • 1.9. List of Abbreviations
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Sterile Injectables CDMO Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Ancillary Market Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
      • 3.2.1.1. Increasing Pipeline and Approvals of Injectables
      • 3.2.1.2. Growing Demand for Biologics and Biosimilars Significantly Supported Market Growth
      • 3.2.1.3. Rise in Investment Across Research & Development Activities for the Development of Novel Therapeutics
      • 3.2.1.4. Increasing Demand for One-stop-shop CDMOs
      • 3.2.1.5. Increasing Outsourcing Services by Pharmaceutical Companies
    • 3.2.2. Market Restraint Analysis
      • 3.2.2.1. Low Barriers to Market Penetration Have Resulted in Pricing Pressure
      • 3.2.2.2. Challenges Related to Quality Control
      • 3.2.2.3. Compliance issues while outsourcing
      • 3.2.2.4. Contractual Obligation
  • 3.3. Technological Advancements
  • 3.4. Pricing Model Analysis
  • 3.5. Clinical Trials Volume Analysis, 2023
    • 3.5.1. Total Number of Clinical Trials, by Region (2023)
    • 3.5.2. Total Number of Clinical Trials, by Phase (2023)
    • 3.5.3. Total Number of Clinical Trials, by Study Design (2023)
    • 3.5.4. Total Number of Clinical Trials, by Key Therapeutic Area (2023)
  • 3.6. Sterile Injectables CDMO Market: Analysis Tools
    • 3.6.1. Porter's Five Forces Analysis
    • 3.6.2. PESTEL Analysis
  • 3.7. COVID-19 Impact Analysis

Chapter 4. Sterile Injectables CDMO Market: Molecule Type Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. Global Sterile Injectables CDMO Market Movement Analysis
  • 4.3. Global Sterile Injectables CDMO Market Size & Trend Analysis, by Molecule Type, 2018 to 2030 (USD Million)
  • 4.4. Small Molecule
    • 4.4.1. Small Molecule Market Estimates and Forecast, 2018 to 2030 (USD Million)
  • 4.5. Large Molecule
    • 4.5.1. Large Molecule Market Estimates and Forecast, 2018 to 2030 (USD Million)

Chapter 5. Sterile Injectables CDMO Market: Product Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. Global Sterile Injectables CDMO Market Movement Analysis
  • 5.3. Global Sterile Injectables CDMO Market Size & Trend Analysis, by Product, 2018 to 2030 (USD Million)
  • 5.4. Pre-filled Syringes
    • 5.4.1. Pre-filled Syringes Market Estimates and Forecast, 2018 to 2030 (USD Million)
  • 5.5. Vials and Ampoules
    • 5.5.1. Vials and Ampoules Market Estimates and Forecast, 2018 to 2030 (USD Million)
  • 5.6. Specialty Injectables
    • 5.6.1. Specialty Injectables Market Estimates and Forecast, 2018 to 2030 (USD Million)
  • 5.7. Others
    • 5.7.1. Others Market Estimates and Forecast, 2018 to 2030 (USD Million)

Chapter 6. Sterile Injectables CDMO Market: Service Estimates & Trend Analysis

  • 6.1. Segment Dashboard
  • 6.2. Global Sterile Injectables CDMO Market Movement Analysis
  • 6.3. Global Sterile Injectables CDMO Market Size & Trend Analysis, by Service, 2018 to 2030 (USD Million)
  • 6.4. Formulation Development
    • 6.4.1. Formulation Development Market Estimates and Forecast, 2018 to 2030 (USD Million)
  • 6.5. Analytical and Testing Services
    • 6.5.1. Analytical and Testing Services Market Estimates and Forecast, 2018 to 2030 (USD Million)
    • 6.5.2. Method Development and Validation
      • 6.5.2.1. Method Development and Validation Market Estimates and Forecast, 2018 to 2030 (USD Million)
    • 6.5.3. Stability Testing
      • 6.5.3.1. Stability Testing Market Estimates and Forecast, 2018 to 2030 (USD Million)
      • 6.5.3.2. Drug Substance
        • 6.5.3.2.1. Drug Substance Market Estimates and Forecast, 2018 to 2030 (USD Million)
      • 6.5.3.3. Stability Indicating Method Validation
        • 6.5.3.3.1. Stability Indicating Method Validation Market Estimates and Forecast, 2018 to 2030 (USD Million)
      • 6.5.3.4. Accelerated Stability Testing
        • 6.5.3.4.1. Accelerated Stability Testing Market Estimates and Forecast, 2018 to 2030 (USD Million)
      • 6.5.3.5. Photostability Testing
        • 6.5.3.5.1. Photostability Testing Market Estimates and Forecast, 2018 to 2030 (USD Million)
      • 6.5.3.6. Other Stability Testing Methods
        • 6.5.3.6.1. Other Stability Testing Methods Market Estimates and Forecast, 2018 to 2030 (USD Million)
    • 6.5.4. Extractable & Leachable Testing
      • 6.5.4.1. Extractable & Leachable Testing Market Estimates and Forecast, 2018 to 2030 (USD Million)
    • 6.5.5. Others
      • 6.5.5.1. Others Market Estimates and Forecast, 2018 to 2030 (USD Million)
  • 6.6. Manufacturing
    • 6.6.1. Manufacturing Market Estimates and Forecast, 2018 to 2030 (USD Million)
    • 6.6.2. Clinical Trial Manufacturing
      • 6.6.2.1. Clinical Trial Manufacturing Market Estimates and Forecast, 2018 to 2030 (USD Million)
    • 6.6.3. Commercial Manufacturing
      • 6.6.3.1. Commercial Manufacturing Market Estimates and Forecast, 2018 to 2030 (USD Million)
    • 6.6.4. Aseptic Fill-Finish Services
      • 6.6.4.1. Aseptic Fill-Finish Services Market Estimates and Forecast, 2018 to 2030 (USD Million)
  • 6.7. Packaging
    • 6.7.1. Packaging Market Estimates and Forecast, 2018 to 2030 (USD Million)
  • 6.8. Storage
    • 6.8.1. Storage Market Estimates and Forecast, 2018 to 2030 (USD Million)
    • 6.8.2. Cold
      • 6.8.2.1. Cold Market Estimates and Forecast, 2018 to 2030 (USD Million)
    • 6.8.3. Non-cold
      • 6.8.3.1. Non-cold Market Estimates and Forecast, 2018 to 2030 (USD Million)
  • 6.9. Others
    • 6.9.1. Others Market Estimates and Forecast, 2018 to 2030 (USD Million)

Chapter 7. Sterile Injectables CDMO Market: Therapeutic Area Estimates & Trend Analysis

  • 7.1. Segment Dashboard
  • 7.2. Global Sterile Injectables CDMO Market Therapeutic Area Movement Analysis
  • 7.3. Global Sterile Injectables CDMO Market Size & Trend Analysis, Therapeutic Area, 2018 to 2030 (USD Million)
  • 7.4. Oncology
    • 7.4.1. Oncology Market Estimates and Forecast, 2018 to 2030 (USD Million)
  • 7.5. Cardiovascular Diseases
    • 7.5.1. Cardiovascular Diseases Market Estimates and Forecast, 2018 to 2030 (USD Million)
  • 7.6. Central Nervous System Diseases
    • 7.6.1. Central Nervous System Diseases Market Estimates and Forecast, 2018 to 2030 (USD Million)
  • 7.7. Infectious Disorders
    • 7.7.1. Infectious Disorders Market Estimates and Forecast, 2018 to 2030 (USD Million)
  • 7.8. Musculoskeletal Diseases
    • 7.8.1. Musculoskeletal Diseases Market Estimates and Forecast, 2018 to 2030 (USD Million)
  • 7.9. Hormonal Diseases
    • 7.9.1. Hormonal Diseases Market Estimates and Forecast, 2018 to 2030 (USD Million)
  • 7.10. Others
    • 7.10.1. Others Market Estimates and Forecast, 2018 to 2030 (USD Million)

Chapter 8. Sterile Injectables CDMO Market: Route of Administration Estimates & Trend Analysis

  • 8.1. Segment Dashboard
  • 8.2. Global Sterile Injectables CDMO Market Route of Administration Movement Analysis
  • 8.3. Global Sterile Injectables CDMO Market Size & Trend Analysis, Route of Administration, 2018 to 2030 (USD Million)
  • 8.4. Subcutaneous (SC)
    • 8.4.1. Subcutaneous (SC) Market Estimates and Forecast, 2018 to 2030 (USD Million)
  • 8.5. Intravenous (IV)
    • 8.5.1. Intravenous (IV) Market Estimates and Forecast, 2018 to 2030 (USD Million)
  • 8.6. Intramuscular (IM)
    • 8.6.1. Intramuscular (IM) Market Estimates and Forecast, 2018 to 2030 (USD Million)
  • 8.7. Others
    • 8.7.1. Others Market Estimates and Forecast, 2018 to 2030 (USD Million)

Chapter 9. Sterile Injectables CDMO Market: Modality by End Use Estimates & Trend Analysis

  • 9.1. Segment Dashboard
  • 9.2. Global Sterile Injectables CDMO Market End Use Movement Analysis
  • 9.3. Global Sterile Injectables CDMO Market Size & Trend Analysis, End Use, 2018 to 2030 (USD Million)
  • 9.4. Pharmaceutical Companies
    • 9.4.1. Pharmaceutical Companies Market Estimates and Forecast, 2018 to 2030 (USD Million)
  • 9.5. Biopharmaceutical Companies
    • 9.5.1. Biopharmaceutical Companies Market Estimates and Forecast, 2018 to 2030 (USD Million)
  • 9.6. Others
    • 9.6.1. Others Market Estimates and Forecast, 2018 to 2030 (USD Million)

Chapter 10. Sterile Injectables CDMO Market: Regional Estimates & Trend Analysis

  • 10.1. Regional Market Share Analysis, 2024 & 2030
  • 10.2. Regional Market Dashboard
  • 10.3. North America
    • 10.3.1. Market Estimates and Forecast, 2018 to 2030 (USD Million)
    • 10.3.2. U.S.
      • 10.3.2.1. Key Country Dynamics
      • 10.3.2.2. Competitive Scenario
      • 10.3.2.3. Regulatory Framework
      • 10.3.2.4. Market Estimates and Forecast, 2018 to 2030 (USD Million)
    • 10.3.3. Canada
      • 10.3.3.1. Key Country Dynamics
      • 10.3.3.2. Competitive Scenario
      • 10.3.3.3. Regulatory Framework
      • 10.3.3.4. Market Estimates and Forecast, 2018 to 2030 (USD Million)
    • 10.3.4. Mexico
      • 10.3.4.1. Key Country Dynamics
      • 10.3.4.2. Competitive Scenario
      • 10.3.4.3. Regulatory Framework
      • 10.3.4.4. Market Estimates and Forecast, 2018 to 2030 (USD Million)
  • 10.4. Europe
    • 10.4.1. Market Estimates and Forecast, 2018 to 2030 (USD Million)
    • 10.4.2. UK
      • 10.4.2.1. Key Country Dynamics
      • 10.4.2.2. Competitive Scenario
      • 10.4.2.3. Regulatory Framework
      • 10.4.2.4. Market Estimates and Forecast, 2018 to 2030 (USD Million)
    • 10.4.3. Germany
      • 10.4.3.1. Key Country Dynamics
      • 10.4.3.2. Competitive Scenario
      • 10.4.3.3. Regulatory Framework
      • 10.4.3.4. Market Estimates and Forecast, 2018 to 2030 (USD Million)
    • 10.4.4. France
      • 10.4.4.1. Key Country Dynamics
      • 10.4.4.2. Competitive Scenario
      • 10.4.4.3. Regulatory Framework
      • 10.4.4.4. Market Estimates and Forecast, 2018 to 2030 (USD Million)
    • 10.4.5. Italy
      • 10.4.5.1. Key Country Dynamics
      • 10.4.5.2. Competitive Scenario
      • 10.4.5.3. Regulatory Framework
      • 10.4.5.4. Market Estimates and Forecast, 2018 to 2030 (USD Million)
    • 10.4.6. Spain
      • 10.4.6.1. Key Country Dynamics
      • 10.4.6.2. Competitive Scenario
      • 10.4.6.3. Regulatory Framework
      • 10.4.6.4. Market Estimates and Forecast, 2018 to 2030 (USD Million)
    • 10.4.7. Denmark
      • 10.4.7.1. Key Country Dynamics
      • 10.4.7.2. Competitive Scenario
      • 10.4.7.3. Regulatory Framework
      • 10.4.7.4. Market Estimates and Forecast, 2018 to 2030 (USD Million)
    • 10.4.8. Sweden
      • 10.4.8.1. Key Country Dynamics
      • 10.4.8.2. Competitive Scenario
      • 10.4.8.3. Regulatory Framework
      • 10.4.8.4. Market Estimates and Forecast, 2018 to 2030 (USD Million)
    • 10.4.9. Norway
      • 10.4.9.1. Key Country Dynamics
      • 10.4.9.2. Competitive Scenario
      • 10.4.9.3. Regulatory Framework
      • 10.4.9.4. Market Estimates and Forecast, 2018 to 2030 (USD Million)
  • 10.5. Asia Pacific
    • 10.5.1. Market Estimates and Forecast, 2018 to 2030 (USD Million)
    • 10.5.2. Japan
      • 10.5.2.1. Key country dynamics
      • 10.5.2.2. Competitive scenario
      • 10.5.2.3. Regulatory framework
      • 10.5.2.4. Japan market estimates and forecasts, 2018 to 2030 (USD Million)
    • 10.5.3. China
      • 10.5.3.1. Key country dynamics
      • 10.5.3.2. Competitive scenario
      • 10.5.3.3. Regulatory framework
      • 10.5.3.4. China market estimates and forecasts, 2018 to 2030 (USD Million)
    • 10.5.4. India
      • 10.5.4.1. Key country dynamics
      • 10.5.4.2. Competitive scenario
      • 10.5.4.3. Regulatory framework
      • 10.5.4.4. India market estimates and forecasts, 2018 to 2030 (USD Million)
    • 10.5.5. South Korea
      • 10.5.5.1. Key country dynamics
      • 10.5.5.2. Competitive scenario
      • 10.5.5.3. Regulatory framework
      • 10.5.5.4. South Korea market estimates and forecasts, 2018 to 2030 (USD Million)
    • 10.5.6. Australia
      • 10.5.6.1. Key country dynamics
      • 10.5.6.2. Competitive scenario
      • 10.5.6.3. Regulatory framework
      • 10.5.6.4. Australia market estimates and forecasts, 2018 to 2030 (USD Million)
    • 10.5.7. Thailand
      • 10.5.7.1. Key country dynamics
      • 10.5.7.2. Competitive scenario
      • 10.5.7.3. Regulatory framework
      • 10.5.7.4. Thailand market estimates and forecasts, 2018 to 2030 (USD Million)
    • 10.5.8. Vietnam
      • 10.5.8.1. Key country dynamics
      • 10.5.8.2. Competitive scenario
      • 10.5.8.3. Regulatory framework
      • 10.5.8.4. Vietnam market estimates and forecasts, 2018 to 2030 (USD Million)
    • 10.5.9. Indonesia
      • 10.5.9.1. Key country dynamics
      • 10.5.9.2. Competitive scenario
      • 10.5.9.3. Regulatory framework
      • 10.5.9.4. Indonesia market estimates and forecasts, 2018 to 2030 (USD Million)
    • 10.5.10. Malaysia
      • 10.5.10.1. Key country dynamics
      • 10.5.10.2. Competitive scenario
      • 10.5.10.3. Regulatory framework
      • 10.5.10.4. Malaysia market estimates and forecasts, 2018 to 2030 (USD Million)
    • 10.5.11. Philippines
      • 10.5.11.1. Key country dynamics
      • 10.5.11.2. Competitive scenario
      • 10.5.11.3. Regulatory framework
      • 10.5.11.4. Philippines market estimates and forecasts, 2018 to 2030 (USD Million)
    • 10.5.12. Singapore
      • 10.5.12.1. Key country dynamics
      • 10.5.12.2. Competitive scenario
      • 10.5.12.3. Regulatory framework
      • 10.5.12.4. Singapore market estimates and forecasts, 2018 to 2030 (USD Million)
  • 10.6. Latin America
    • 10.6.1. Market Estimates and Forecast, 2018 to 2030 (USD Million)
    • 10.6.2. Brazil
      • 10.6.2.1. Key Country Dynamics
      • 10.6.2.2. Competitive Scenario
      • 10.6.2.3. Regulatory Framework
      • 10.6.2.4. Market Estimates and Forecast, 2018 to 2030 (USD Million)
    • 10.6.3. Argentina
      • 10.6.3.1. Key Country Dynamics
      • 10.6.3.2. Competitive Scenario
      • 10.6.3.3. Regulatory Framework
      • 10.6.3.4. Market Estimates and Forecast, 2018 to 2030 (USD Million)
  • 10.7. MEA
    • 10.7.1. Market Estimates and Forecast, 2018 to 2030 (USD Million)
    • 10.7.2. South Africa
      • 10.7.2.1. Key Country Dynamics
      • 10.7.2.2. Competitive Scenario
      • 10.7.2.3. Regulatory Framework
      • 10.7.2.4. Market Estimates and Forecast, 2018 to 2030 (USD Million)
    • 10.7.3. Saudi Arabia
      • 10.7.3.1. Key Country Dynamics
      • 10.7.3.2. Competitive Scenario
      • 10.7.3.3. Regulatory Framework
      • 10.7.3.4. Market Estimates and Forecast, 2018 to 2030 (USD Million)
    • 10.7.4. UAE
      • 10.7.4.1. Key Country Dynamics
      • 10.7.4.2. Competitive Scenario
      • 10.7.4.3. Regulatory Framework
      • 10.7.4.4. Market Estimates and Forecast, 2018 to 2030 (USD Million)
    • 10.7.5. Kuwait
      • 10.7.5.1. Key Country Dynamics
      • 10.7.5.2. Competitive Scenario
      • 10.7.5.3. Regulatory Framework
      • 10.7.5.4. Market Estimates and Forecast, 2018 to 2030 (USD Million)

Chapter 11. Competitive Landscape

  • 11.1. Market Participant Categorization
    • 11.1.1. Market Leaders
    • 11.1.2. Emerging Players
  • 11.2. Service Heat Map Analysis (a comparative analysis of the players together)
  • 11.3. Company Profiles
    • 11.3.1. Boehringer Ingelheim International GmbH
      • 11.3.1.1. Company Overview
      • 11.3.1.2. Financial Performance
      • 11.3.1.3. Service Benchmarking
      • 11.3.1.4. Strategic Initiatives
    • 11.3.2. Baxter Simtra BioPharma Solutions
      • 11.3.2.1. Company Overview
      • 11.3.2.2. Financial Performance
      • 11.3.2.3. Service Benchmarking
      • 11.3.2.4. Strategic Initiatives
    • 11.3.3. Vetter Pharma International GmbH
      • 11.3.3.1. Company Overview
      • 11.3.3.2. Financial Performance
      • 11.3.3.3. Service Benchmarking
      • 11.3.3.4. Strategic Initiatives
    • 11.3.4. Recipharm AB
      • 11.3.4.1. Company Overview
      • 11.3.4.2. Financial Performance
      • 11.3.4.3. Service Benchmarking
      • 11.3.4.4. Strategic Initiatives
    • 11.3.5. Aenova Group
      • 11.3.5.1. Company Overview
      • 11.3.5.2. Financial Performance
      • 11.3.5.3. Service Benchmarking
      • 11.3.5.4. Strategic Initiatives
    • 11.3.6. Fresenius Kabi Contract Manufacturing (Fresenius Kabi AG)
      • 11.3.6.1. Company Overview
      • 11.3.6.2. Financial Performance
      • 11.3.6.3. Service Benchmarking
      • 11.3.6.4. Strategic Initiatives
    • 11.3.7. Unither Pharmaceuticals
      • 11.3.7.1. Company Overview
      • 11.3.7.2. Financial Performance
      • 11.3.7.3. Service Benchmarking
      • 11.3.7.4. Strategic Initiatives
    • 11.3.8. FAMAR Health Care Services
      • 11.3.8.1. Company Overview
      • 11.3.8.2. Financial Performance
      • 11.3.8.3. Service Benchmarking
      • 11.3.8.4. Strategic Initiatives
    • 11.3.9. Ajinomoto Bio-Pharma
      • 11.3.9.1. Company Overview
      • 11.3.9.2. Financial Performance
      • 11.3.9.3. Service Benchmarking
      • 11.3.9.4. Strategic Initiatives
    • 11.3.10. PCI Pharma Services
      • 11.3.10.1. Company Overview
      • 11.3.10.2. Financial Performance
      • 11.3.10.3. Service Benchmarking
      • 11.3.10.4. Strategic Initiatives
    • 11.3.11. IDT Biologika GmbH
      • 11.3.11.1. Company Overview
      • 11.3.11.2. Financial Performance
      • 11.3.11.3. Service Benchmarking
      • 11.3.11.4. Strategic Initiatives
    • 11.3.12. Alcami Corporation
      • 11.3.12.1. Company Overview
      • 11.3.12.2. Financial Performance
      • 11.3.12.3. Service Benchmarking
      • 11.3.12.4. Strategic Initiatives
    • 11.3.13. Fareva Group
      • 11.3.13.1. Company Overview
      • 11.3.13.2. Financial Performance
      • 11.3.13.3. Service Benchmarking
      • 11.3.13.4. Strategic Initiatives
    • 11.3.14. Eurofins Scientific
      • 11.3.14.1. Company Overview
      • 11.3.14.2. Financial Performance
      • 11.3.14.3. Service Benchmarking
      • 11.3.14.4. Strategic Initiatives
    • 11.3.15. Siegfried AG
      • 11.3.15.1. Company Overview
      • 11.3.15.2. Financial Performance
      • 11.3.15.3. Service Benchmarking
      • 11.3.15.4. Strategic Initiatives
    • 11.3.16. Torbay Pharmaceuticals
      • 11.3.16.1. Company Overview
      • 11.3.16.2. Financial Performance
      • 11.3.16.3. Service Benchmarking
      • 11.3.16.4. Strategic Initiatives
    • 11.3.17. Pfizer CentreOne (Pfizer Inc)
      • 11.3.17.1. Company Overview
      • 11.3.17.2. Financial Performance
      • 11.3.17.3. Service Benchmarking
      • 11.3.17.4. Strategic Initiatives

List of Tables

  • Table 1 List of Secondary Sources
  • Table 2 List of Abbreviations
  • Table 3 List of Abbreviations
  • Table 4 Global Sterile Injectables CDMO Market, by Molecule, 2018 - 2030 (USD Million)
  • Table 5 Global Sterile Injectables CDMO Market, by Product, 2018 - 2030 (USD Million)
  • Table 6 Global Sterile Injectables CDMO Market, by Service, 2018 - 2030 (USD Million)
  • Table 7 Global Sterile Injectables CDMO Market, by Therapeutic Area, 2018 - 2030 (USD Million)
  • Table 8 Global Sterile Injectables CDMO Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 9 Global Sterile Injectables CDMO Market, by End Use, 2018 - 2030 (USD Million)
  • Table 10 Global Sterile Injectables CDMO Market, by Region, 2018 - 2030 (USD Million)
  • Table 11 North America Sterile Injectables CDMO Market, by Country, 2018 - 2030 (USD Million)
  • Table 12 North America Sterile Injectables CDMO Market, by Molecule, 2018 - 2030 (USD Million)
  • Table 13 North America Sterile Injectables CDMO Market, by Product, 2018 - 2030 (USD Million)
  • Table 14 North America Sterile Injectables CDMO Market, by Service, 2018 - 2030 (USD Million)
  • Table 15 North America Sterile Injectables CDMO Market, by Therapeutic Area, 2018 - 2030 (USD Million)
  • Table 16 North America Sterile Injectables CDMO Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 17 North America Sterile Injectables CDMO Market, by End Use, 2018 - 2030 (USD Million)
  • Table 18 North America Sterile Injectables CDMO Market, by Region, 2018 - 2030 (USD Million)
  • Table 19 U.S. Sterile Injectables CDMO Market, by Molecule, 2018 - 2030 (USD Million)
  • Table 20 U.S. Sterile Injectables CDMO Market, by Product, 2018 - 2030 (USD Million)
  • Table 21 U.S. Sterile Injectables CDMO Market, by Service, 2018 - 2030 (USD Million)
  • Table 22 U.S. Sterile Injectables CDMO Market, by Therapeutic Area, 2018 - 2030 (USD Million)
  • Table 23 U.S. Sterile Injectables CDMO Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 24 U.S. Sterile Injectables CDMO Market, by End Use, 2018 - 2030 (USD Million)
  • Table 25 Canada Sterile Injectables CDMO Market, by Molecule, 2018 - 2030 (USD Million)
  • Table 26 Canada Sterile Injectables CDMO Market, by Product, 2018 - 2030 (USD Million)
  • Table 27 Canada Sterile Injectables CDMO Market, by Service, 2018 - 2030 (USD Million)
  • Table 28 Canada Sterile Injectables CDMO Market, by Therapeutic Area, 2018 - 2030 (USD Million)
  • Table 29 Canada Sterile Injectables CDMO Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 30 Canada Sterile Injectables CDMO Market, by End Use, 2018 - 2030 (USD Million)
  • Table 31 Mexico Sterile Injectables CDMO Market, by Molecule, 2018 - 2030 (USD Million)
  • Table 32 Mexico Sterile Injectables CDMO Market, by Product, 2018 - 2030 (USD Million)
  • Table 33 Mexico Sterile Injectables CDMO Market, by Service, 2018 - 2030 (USD Million)
  • Table 34 Mexico Sterile Injectables CDMO Market, by Therapeutic Area, 2018 - 2030 (USD Million)
  • Table 35 Mexico Sterile Injectables CDMO Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 36 Mexico Sterile Injectables CDMO Market, by End Use, 2018 - 2030 (USD Million)
  • Table 37 Europe Sterile Injectables CDMO Market, by Country, 2018 - 2030 (USD Million)
  • Table 38 Europe Sterile Injectables CDMO Market, by Molecule, 2018 - 2030 (USD Million)
  • Table 39 Europe Sterile Injectables CDMO Market, by Product, 2018 - 2030 (USD Million)
  • Table 40 Europe Sterile Injectables CDMO Market, by Service, 2018 - 2030 (USD Million)
  • Table 41 Europe Sterile Injectables CDMO Market, by Therapeutic Area, 2018 - 2030 (USD Million)
  • Table 42 Europe Sterile Injectables CDMO Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 43 Europe Sterile Injectables CDMO Market, by End Use, 2018 - 2030 (USD Million)
  • Table 44 Europe Sterile Injectables CDMO Market, by Region, 2018 - 2030 (USD Million)
  • Table 45 UK Sterile Injectables CDMO Market, by Molecule, 2018 - 2030 (USD Million)
  • Table 46 UK Sterile Injectables CDMO Market, by Product, 2018 - 2030 (USD Million)
  • Table 47 UK Sterile Injectables CDMO Market, by Service, 2018 - 2030 (USD Million)
  • Table 48 UK Sterile Injectables CDMO Market, by Therapeutic Area, 2018 - 2030 (USD Million)
  • Table 49 UK Sterile Injectables CDMO Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 50 UK Sterile Injectables CDMO Market, by End Use, 2018 - 2030 (USD Million)
  • Table 51 Germany Sterile Injectables CDMO Market, by Molecule, 2018 - 2030 (USD Million)
  • Table 52 Germany Sterile Injectables CDMO Market, by Product, 2018 - 2030 (USD Million)
  • Table 53 Germany Sterile Injectables CDMO Market, by Service, 2018 - 2030 (USD Million)
  • Table 54 Germany Sterile Injectables CDMO Market, by Therapeutic Area, 2018 - 2030 (USD Million)
  • Table 55 Germany Sterile Injectables CDMO Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 56 Germany Sterile Injectables CDMO Market, by End Use, 2018 - 2030 (USD Million)
  • Table 57 France Sterile Injectables CDMO Market, by Molecule, 2018 - 2030 (USD Million)
  • Table 58 France Sterile Injectables CDMO Market, by Product, 2018 - 2030 (USD Million)
  • Table 59 France Sterile Injectables CDMO Market, by Service, 2018 - 2030 (USD Million)
  • Table 60 France Sterile Injectables CDMO Market, by Therapeutic Area, 2018 - 2030 (USD Million)
  • Table 61 France Sterile Injectables CDMO Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 62 France Sterile Injectables CDMO Market, by End Use, 2018 - 2030 (USD Million)
  • Table 63 Italy Sterile Injectables CDMO Market, by Molecule, 2018 - 2030 (USD Million)
  • Table 64 Italy Sterile Injectables CDMO Market, by Product, 2018 - 2030 (USD Million)
  • Table 65 Italy Sterile Injectables CDMO Market, by Service, 2018 - 2030 (USD Million)
  • Table 66 Italy Sterile Injectables CDMO Market, by Therapeutic Area, 2018 - 2030 (USD Million)
  • Table 67 Italy Sterile Injectables CDMO Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 68 Italy Sterile Injectables CDMO Market, by End Use, 2018 - 2030 (USD Million)
  • Table 69 Spain Sterile Injectables CDMO Market, by Molecule, 2018 - 2030 (USD Million)
  • Table 70 Spain Sterile Injectables CDMO Market, by Product, 2018 - 2030 (USD Million)
  • Table 71 Spain Sterile Injectables CDMO Market, by Service, 2018 - 2030 (USD Million)
  • Table 72 Spain Sterile Injectables CDMO Market, by Therapeutic Area, 2018 - 2030 (USD Million)
  • Table 73 Spain Sterile Injectables CDMO Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 74 Spain Sterile Injectables CDMO Market, by End Use, 2018 - 2030 (USD Million)
  • Table 75 Denmark Sterile Injectables CDMO Market, by Molecule, 2018 - 2030 (USD Million)
  • Table 76 Denmark Sterile Injectables CDMO Market, by Product, 2018 - 2030 (USD Million)
  • Table 77 Denmark Sterile Injectables CDMO Market, by Service, 2018 - 2030 (USD Million)
  • Table 78 Denmark Sterile Injectables CDMO Market, by Therapeutic Area, 2018 - 2030 (USD Million)
  • Table 79 Denmark Sterile Injectables CDMO Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 80 Denmark Sterile Injectables CDMO Market, by End Use, 2018 - 2030 (USD Million)
  • Table 81 Sweden Sterile Injectables CDMO Market, by Molecule, 2018 - 2030 (USD Million)
  • Table 82 Sweden Sterile Injectables CDMO Market, by Product, 2018 - 2030 (USD Million)
  • Table 83 Sweden Sterile Injectables CDMO Market, by Service, 2018 - 2030 (USD Million)
  • Table 84 Sweden Sterile Injectables CDMO Market, by Therapeutic Area, 2018 - 2030 (USD Million)
  • Table 85 Sweden Sterile Injectables CDMO Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 86 Sweden Sterile Injectables CDMO Market, by End Use, 2018 - 2030 (USD Million)
  • Table 87 Norway Sterile Injectables CDMO Market, by Molecule, 2018 - 2030 (USD Million)
  • Table 88 Norway Sterile Injectables CDMO Market, by Product, 2018 - 2030 (USD Million)
  • Table 89 Norway Sterile Injectables CDMO Market, by Service, 2018 - 2030 (USD Million)
  • Table 90 Norway Sterile Injectables CDMO Market, by Therapeutic Area, 2018 - 2030 (USD Million)
  • Table 91 Norway Sterile Injectables CDMO Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 92 Norway Sterile Injectables CDMO Market, by End Use, 2018 - 2030 (USD Million)
  • Table 93 Asia Pacific Sterile Injectables CDMO Market, by Country, 2018 - 2030 (USD Million)
  • Table 94 Asia Pacific Sterile Injectables CDMO Market, by Molecule, 2018 - 2030 (USD Million)
  • Table 95 Asia Pacific Sterile Injectables CDMO Market, by Product, 2018 - 2030 (USD Million)
  • Table 96 Asia Pacific Sterile Injectables CDMO Market, by Service, 2018 - 2030 (USD Million)
  • Table 97 Asia Pacific Sterile Injectables CDMO Market, by Therapeutic Area, 2018 - 2030 (USD Million)
  • Table 98 Asia Pacific Sterile Injectables CDMO Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 99 Asia Pacific Sterile Injectables CDMO Market, by End Use, 2018 - 2030 (USD Million)
  • Table 100 Asia Pacific Sterile Injectables CDMO Market, by Region, 2018 - 2030 (USD Million)
  • Table 101 Japan Sterile Injectables CDMO Market, by Molecule, 2018 - 2030 (USD Million)
  • Table 102 Japan Sterile Injectables CDMO Market, by Product, 2018 - 2030 (USD Million)
  • Table 103 Japan Sterile Injectables CDMO Market, by Service, 2018 - 2030 (USD Million)
  • Table 104 Japan Sterile Injectables CDMO Market, by Therapeutic Area, 2018 - 2030 (USD Million)
  • Table 105 Japan Sterile Injectables CDMO Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 106 Japan Sterile Injectables CDMO Market, by End Use, 2018 - 2030 (USD Million)
  • Table 107 China Sterile Injectables CDMO Market, by Molecule, 2018 - 2030 (USD Million)
  • Table 108 China Sterile Injectables CDMO Market, by Product, 2018 - 2030 (USD Million)
  • Table 109 China Sterile Injectables CDMO Market, by Service, 2018 - 2030 (USD Million)
  • Table 110 China Sterile Injectables CDMO Market, by Therapeutic Area, 2018 - 2030 (USD Million)
  • Table 111 China Sterile Injectables CDMO Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 112 China Sterile Injectables CDMO Market, by End Use, 2018 - 2030 (USD Million)
  • Table 113 India Sterile Injectables CDMO Market, by Molecule, 2018 - 2030 (USD Million)
  • Table 114 India Sterile Injectables CDMO Market, by Product, 2018 - 2030 (USD Million)
  • Table 115 India Sterile Injectables CDMO Market, by Service, 2018 - 2030 (USD Million)
  • Table 116 India Sterile Injectables CDMO Market, by Therapeutic Area, 2018 - 2030 (USD Million)
  • Table 117 India Sterile Injectables CDMO Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 118 India Sterile Injectables CDMO Market, by End Use, 2018 - 2030 (USD Million)
  • Table 119 South Korea Sterile Injectables CDMO Market, by Molecule, 2018 - 2030 (USD Million)
  • Table 120 South Korea Sterile Injectables CDMO Market, by Product, 2018 - 2030 (USD Million)
  • Table 121 South Korea Sterile Injectables CDMO Market, by Service, 2018 - 2030 (USD Million)
  • Table 122 South Korea Sterile Injectables CDMO Market, by Therapeutic Area, 2018 - 2030 (USD Million)
  • Table 123 South Korea Sterile Injectables CDMO Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 124 South Korea Sterile Injectables CDMO Market, by End Use, 2018 - 2030 (USD Million)
  • Table 125 Australia Sterile Injectables CDMO Market, by Molecule, 2018 - 2030 (USD Million)
  • Table 126 Australia Sterile Injectables CDMO Market, by Product, 2018 - 2030 (USD Million)
  • Table 127 Australia Sterile Injectables CDMO Market, by Service, 2018 - 2030 (USD Million)
  • Table 128 Australia Sterile Injectables CDMO Market, by Therapeutic Area, 2018 - 2030 (USD Million)
  • Table 129 Australia Sterile Injectables CDMO Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 130 Australia Sterile Injectables CDMO Market, by End Use, 2018 - 2030 (USD Million)
  • Table 131 Thailand Sterile Injectables CDMO Market, by Molecule, 2018 - 2030 (USD Million)
  • Table 132 Thailand Sterile Injectables CDMO Market, by Product, 2018 - 2030 (USD Million)
  • Table 133 Thailand Sterile Injectables CDMO Market, by Service, 2018 - 2030 (USD Million)
  • Table 134 Thailand Sterile Injectables CDMO Market, by Therapeutic Area, 2018 - 2030 (USD Million)
  • Table 135 Thailand Sterile Injectables CDMO Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 136 Thailand Sterile Injectables CDMO Market, by End Use, 2018 - 2030 (USD Million)
  • Table 137 Vietnam Sterile Injectables CDMO Market, by Molecule, 2018 - 2030 (USD Million)
  • Table 138 Vietnam Sterile Injectables CDMO Market, by Product, 2018 - 2030 (USD Million)
  • Table 139 Vietnam Sterile Injectables CDMO Market, by Service, 2018 - 2030 (USD Million)
  • Table 140 Vietnam Sterile Injectables CDMO Market, by Therapeutic Area, 2018 - 2030 (USD Million)
  • Table 141 Vietnam Sterile Injectables CDMO Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 142 Vietnam Sterile Injectables CDMO Market, by End Use, 2018 - 2030 (USD Million)
  • Table 143 Indonesia Sterile Injectables CDMO Market, by Molecule, 2018 - 2030 (USD Million)
  • Table 144 Indonesia Sterile Injectables CDMO Market, by Product, 2018 - 2030 (USD Million)
  • Table 145 Indonesia Sterile Injectables CDMO Market, by Service, 2018 - 2030 (USD Million)
  • Table 146 Indonesia Sterile Injectables CDMO Market, by Therapeutic Area, 2018 - 2030 (USD Million)
  • Table 147 Indonesia Sterile Injectables CDMO Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 148 Indonesia Sterile Injectables CDMO Market, by End Use, 2018 - 2030 (USD Million)
  • Table 149 Malaysia Sterile Injectables CDMO Market, by Molecule, 2018 - 2030 (USD Million)
  • Table 150 Malaysia Sterile Injectables CDMO Market, by Product, 2018 - 2030 (USD Million)
  • Table 151 Malaysia Sterile Injectables CDMO Market, by Service, 2018 - 2030 (USD Million)
  • Table 152 Malaysia Sterile Injectables CDMO Market, by Therapeutic Area, 2018 - 2030 (USD Million)
  • Table 153 Malaysia Sterile Injectables CDMO Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 154 Malaysia Sterile Injectables CDMO Market, by End Use, 2018 - 2030 (USD Million)
  • Table 155 Philippines Sterile Injectables CDMO Market, by Molecule, 2018 - 2030 (USD Million)
  • Table 156 Philippines Sterile Injectables CDMO Market, by Product, 2018 - 2030 (USD Million)
  • Table 157 Philippines Sterile Injectables CDMO Market, by Service, 2018 - 2030 (USD Million)
  • Table 158 Philippines Sterile Injectables CDMO Market, by Therapeutic Area, 2018 - 2030 (USD Million)
  • Table 159 Philippines Sterile Injectables CDMO Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 160 Philippines Sterile Injectables CDMO Market, by End Use, 2018 - 2030 (USD Million)
  • Table 161 Singapore Sterile Injectables CDMO Market, by Molecule, 2018 - 2030 (USD Million)
  • Table 162 Singapore Sterile Injectables CDMO Market, by Product, 2018 - 2030 (USD Million)
  • Table 163 Singapore Sterile Injectables CDMO Market, by Service, 2018 - 2030 (USD Million)
  • Table 164 Singapore Sterile Injectables CDMO Market, by Therapeutic Area, 2018 - 2030 (USD Million)
  • Table 165 Singapore Sterile Injectables CDMO Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 166 Singapore Sterile Injectables CDMO Market, by End Use, 2018 - 2030 (USD Million)
  • Table 167 Latin America Sterile Injectables CDMO Market, by Country, 2018 - 2030 (USD Million)
  • Table 168 Latin America Sterile Injectables CDMO Market, by Molecule, 2018 - 2030 (USD Million)
  • Table 169 Latin America Sterile Injectables CDMO Market, by Product, 2018 - 2030 (USD Million)
  • Table 170 Latin America Sterile Injectables CDMO Market, by Service, 2018 - 2030 (USD Million)
  • Table 171 Latin America Sterile Injectables CDMO Market, by Therapeutic Area, 2018 - 2030 (USD Million)
  • Table 172 Latin America Sterile Injectables CDMO Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 173 Latin America Sterile Injectables CDMO Market, by End Use, 2018 - 2030 (USD Million)
  • Table 174 Latin America Sterile Injectables CDMO Market, by Region, 2018 - 2030 (USD Million)
  • Table 175 Brazil Sterile Injectables CDMO Market, by Molecule, 2018 - 2030 (USD Million)
  • Table 176 Brazil Sterile Injectables CDMO Market, by Product, 2018 - 2030 (USD Million)
  • Table 177 Brazil Sterile Injectables CDMO Market, by Service, 2018 - 2030 (USD Million)
  • Table 178 Brazil Sterile Injectables CDMO Market, by Therapeutic Area, 2018 - 2030 (USD Million)
  • Table 179 Brazil Sterile Injectables CDMO Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 180 Brazil Sterile Injectables CDMO Market, by End Use, 2018 - 2030 (USD Million)
  • Table 181 Argentina Sterile Injectables CDMO Market, by Molecule, 2018 - 2030 (USD Million)
  • Table 182 Argentina Sterile Injectables CDMO Market, by Product, 2018 - 2030 (USD Million)
  • Table 183 Argentina Sterile Injectables CDMO Market, by Service, 2018 - 2030 (USD Million)
  • Table 184 Argentina Sterile Injectables CDMO Market, by Therapeutic Area, 2018 - 2030 (USD Million)
  • Table 185 Argentina Sterile Injectables CDMO Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 186 Argentina Sterile Injectables CDMO Market, by End Use, 2018 - 2030 (USD Million)
  • Table 187 Middle East & Africa Sterile Injectables CDMO Market, by Country, 2018 - 2030 (USD Million)
  • Table 188 Middle East & Africa Sterile Injectables CDMO Market, by Molecule, 2018 - 2030 (USD Million)
  • Table 189 Middle East & Africa Sterile Injectables CDMO Market, by Product, 2018 - 2030 (USD Million)
  • Table 190 Middle East & Africa Sterile Injectables CDMO Market, by Service, 2018 - 2030 (USD Million)
  • Table 191 Middle East & Africa Sterile Injectables CDMO Market, by Therapeutic Area, 2018 - 2030 (USD Million)
  • Table 192 Middle East & Africa Sterile Injectables CDMO Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 193 Middle East & Africa Sterile Injectables CDMO Market, by End Use, 2018 - 2030 (USD Million)
  • Table 194 Middle East & Africa Sterile Injectables CDMO Market, by Region, 2018 - 2030 (USD Million)
  • Table 195 South Africa Sterile Injectables CDMO Market, by Molecule, 2018 - 2030 (USD Million)
  • Table 196 South Africa Sterile Injectables CDMO Market, by Product, 2018 - 2030 (USD Million)
  • Table 197 South Africa Sterile Injectables CDMO Market, by Service, 2018 - 2030 (USD Million)
  • Table 198 South Africa Sterile Injectables CDMO Market, by Therapeutic Area, 2018 - 2030 (USD Million)
  • Table 199 Saudi Arabia Sterile Injectables CDMO Market, by Molecule, 2018 - 2030 (USD Million)
  • Table 200 Saudi Arabia Sterile Injectables CDMO Market, by Product, 2018 - 2030 (USD Million)
  • Table 201 Saudi Arabia Sterile Injectables CDMO Market, by Service, 2018 - 2030 (USD Million)
  • Table 202 Saudi Arabia Sterile Injectables CDMO Market, by Therapeutic Area, 2018 - 2030 (USD Million)
  • Table 203 UAE Sterile Injectables CDMO Market, by Molecule, 2018 - 2030 (USD Million)
  • Table 204 UAE Sterile Injectables CDMO Market, by Product, 2018 - 2030 (USD Million)
  • Table 205 UAE Sterile Injectables CDMO Market, by Service, 2018 - 2030 (USD Million)
  • Table 206 UAE Sterile Injectables CDMO Market, by Therapeutic Area, 2018 - 2030 (USD Million)
  • Table 207 Kuwait Sterile Injectables CDMO Market, by Molecule, 2018 - 2030 (USD Million)
  • Table 208 Kuwait Sterile Injectables CDMO Market, by Product, 2018 - 2030 (USD Million)
  • Table 209 Kuwait Sterile Injectables CDMO Market, by Service, 2018 - 2030 (USD Million)
  • Table 210 Kuwait Sterile Injectables CDMO Market, by Therapeutic Area, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Sterile injectables CDMO market segmentation
  • Fig. 2 Market research process
  • Fig. 3 Information procurement
  • Fig. 4 Primary research pattern
  • Fig. 5 Market research approaches
  • Fig. 6 Market formulation & validation
  • Fig. 7 Commodity flow analysis
  • Fig. 8 Value-chain-based sizing & forecasting
  • Fig. 9 QFD model sizing & forecasting
  • Fig. 10 Bottom-up approach
  • Fig. 11 Market snapshot
  • Fig. 12 Competitive landscape snapshot
  • Fig. 13 Parent market outlook, 2023 (USD Billion)
  • Fig. 14 Ancillary market outlook, 2023 (USD Billion)
  • Fig. 15 Sterile injectables CDMO market dynamics
  • Fig. 16 US FDA biologics approval
  • Fig. 17 Average cost by phase
  • Fig. 18 Clinical trial cost per indication (USD millions)
  • Fig. 19 Average cost of clinical trials by major countries
  • Fig. 20 Porter's five forces analysis
  • Fig. 21 Sterile injectables CDMO market: PESTEL analysis
  • Fig. 22 Sterile injectables CDMO market: Molecule type outlook and key takeaways
  • Fig. 23 Sterile injectables CDMO market: Molecule type movement analysis
  • Fig. 24 Small molecule market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 25 Large molecule market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 26 Sterile injectables CDMO market: Product outlook and key takeaways
  • Fig. 27 Sterile injectables CDMO market: Product movement analysis
  • Fig. 28 Prefilled syringes market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 29 Vials and ampoules market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 30 Specialty injectables market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 31 Others market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 32 Sterile injectables CDMO market: Service outlook and key takeaways
  • Fig. 33 Sterile injectables CDMO market: Service movement analysis
  • Fig. 34 Formulation development market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 35 Analytical and testing services market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 36 Method development and validation market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 37 Stability testing market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 38 Drug substance market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 39 Stability-indicating method validation market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 40 Accelerated stability testing market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 41 Photostability testing market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 42 Other stability testing methods market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 43 Extractable & leachable testing market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 44 Others market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 45 Manufacturing market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 46 Clinical trial manufacturing market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 47 Commercial manufacturing market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 48 Aseptic fill-finish services market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 49 Packaging market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 50 Storage market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 51 Cold storage market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 52 Non-cold storage market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 53 Others market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 54 Sterile injectables CDMO market: Therapeutic area outlook and key takeaways
  • Fig. 55 Sterile injectables CDMO market: Therapeutic area movement analysis
  • Fig. 56 Oncology market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 57 Cardiovascular diseases market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 58 Central nervous system diseases market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 59 Infectious disorders market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 60 Musculoskeletal diseases market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 61 Hormonal diseases market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 62 Others market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 63 Sterile injectables CDMO market: Route of administration outlook and key takeaways
  • Fig. 64 Sterile injectables CDMO market: Route of administration movement analysis
  • Fig. 65 Subcutaneous market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 66 Intravenous (IV) market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 67 Intramuscular (IM) market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 68 Others market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 69 Sterile injectables CDMO market: End-use outlook and key takeaways
  • Fig. 70 Sterile injectables CDMO market: End-use movement analysis
  • Fig. 71 Pharmaceutical companies market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 72 Biopharmaceutical companies market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 73 Others market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 74 Regional market: Key takeaways
  • Fig. 75 Regional marketplace: Key takeaways 1
  • Fig. 76 Regional marketplace: Key takeaways 2
  • Fig. 77 North America sterile injectables CDMO market estimates and forecast, 2018 - 2030 (, 2018 - 2030 (, 2018 - 2030 (USD Million)
  • Fig. 78 Key country dynamics
  • Fig. 79 US sterile injectables CDMO market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 80 Key country dynamics
  • Fig. 81 Canada sterile injectables CDMO market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 82 Key country dynamics
  • Fig. 83 Mexico sterile injectables CDMO market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 84 Europe sterile injectables CDMO market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 85 Key country dynamics
  • Fig. 86 UK sterile injectables CDMO market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 87 Key country dynamics
  • Fig. 88 Germany sterile injectables CDMO market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 89 Key country dynamics
  • Fig. 90 France sterile injectables CDMO market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 91 Key country dynamics
  • Fig. 92 Italy sterile injectables CDMO market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 93 Key country dynamics
  • Fig. 94 Spain sterile injectables CDMO market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 95 Key country dynamics
  • Fig. 96 Denmark sterile injectables CDMO market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 97 Key country dynamics
  • Fig. 98 Sweden sterile injectables CDMO market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 99 Key country dynamics
  • Fig. 100 Norway sterile injectables CDMO market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 101 Asia Pacific sterile injectables CDMO market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 102 Japan sterile injectables CDMO market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 103 Key country dynamics
  • Fig. 104 China sterile injectables CDMO market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 105 Key country dynamics
  • Fig. 106 India sterile injectables CDMO market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 107 Key country dynamics
  • Fig. 108 South Korea sterile injectables CDMO market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 109 Key country dynamics
  • Fig. 110 Australia sterile injectables CDMO market estimates and forecast, 2018 - 2030, (USD Million)
  • Fig. 111 Thailand sterile injectables CDMO market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 112 Key country dynamics
  • Fig. 113 Vietnam sterile injectables CDMO market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 114 Key country dynamics
  • Fig. 115 Indonesia sterile injectables CDMO market estimates and forecast, 2018 - 2030, (USD Million)
  • Fig. 116 Key country dynamics
  • Fig. 117 Malaysia sterile injectables CDMO market estimates and forecast, 2018 - 2030, (USD Million)
  • Fig. 118 Key country dynamics
  • Fig. 119 Philippines sterile injectables CDMO market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 120 Key country dynamics
  • Fig. 121 Singapore sterile injectables CDMO market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 122 Latin America sterile injectables CDMO market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 123 Key country dynamics
  • Fig. 124 Brazil sterile injectables CDMO market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 125 Key country dynamics
  • Fig. 126 Argentina sterile injectable CDMO market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 127 Key country dynamics
  • Fig. 128 Colombia sterile injectable CDMO market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 129 Key country dynamics
  • Fig. 130 Chile sterile injectable CDMO market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 131 MEA sterile injectable CDMO market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 132 Key country dynamics
  • Fig. 133 South Africa sterile injectables CDMO market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 134 Key country dynamics
  • Fig. 135 Saudi Arabia sterile injectable CDMO market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 136 Key country dynamics
  • Fig. 137 UAE sterile injectable CDMO market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 138 Key country dynamics
  • Fig. 139 Kuwait sterile injectables CDMO market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 140 Key company categorization
  • Fig. 141 Service heat map analysis
  • Fig. 142 Competitive assessment analysis
  • Fig. 143 Strategic framework